Почетна › Steatotna bolest jetre › Охајо
Kliničke studije za Steatotna bolest jetre u državi Охајо
15 studija za Steatotna bolest jetre traži učesnike na lokacijama u državi Охајо.
Gradovi u državi Охајо
Zvanični tekst studije (na engleskom)
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Cleveland
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06613698A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Akron
- Akero Clinical Study Site, Brooklyn
- Akero Clinical Study Site, Springboro
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Akron Gastro Research, Akron
- Digestive Specialists, Dayton
- Dayton Gastroenterology - Englewood, Dayton
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Springboro
- GSK Investigational Site, Westlake
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Westlake
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07701993Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Ohio Clinical Trials, Columbus
Тражи се учесникОпсервациона студија
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07122700A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Akron
- 89bio Clinical Study Site, Cincinnati
- 89bio Clinical Study Site, Cleveland
- и још 5
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Akron
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
- и још 4
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Akron Gastro Research, Akron
- Dayton Gastroenterology - Beavercreek, Beavercreek
- Clinical Research Institute of Ohio - Brooklyn, Brooklyn
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Cleveland Clinic, Cleveland
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 28. 9. 2026. · NCT05832229Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 2
Узраст од 5 до 16 · Оба пола · Ажурирано 22. 9. 2026. · NCT06133101A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Akron
- GSK Investigational Site, Springboro
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 17. 9. 2026. · NCT07221188Fibrosis Lessens After Metabolic Surgery
- Cleveland Clinic, Cleveland
Тражи се учесникФаза 4Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 31. 7. 2026. · NCT06374875A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Akron
- GSK Investigational Site, Springboro
- GSK Investigational Site, Westlake
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227Milk Thistle Clinical Trial in Pediatric NAFLD
- University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 2
Узраст од 9 до 22 · Оба пола · Ажурирано 27. 1. 2026. · NCT06477146Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.